NUR2474 / NUR 2474 Pharmacology for Professional
Nursing Final Exam Quiz Bank | Already Rated A| More
than 100 Questions and Answers| Rasmussen College
1. A patient who is taking warfarin (Coumadin) has just vomited blood. The nurse notifies the
provider, who orders lab work revealing a PT of 42 seconds and an INR of 3. 5. The nurse
will expect to administer:
A. phytonadione (vitamin K1) 1 mg IV over 1 hour.
B. phytonadione (vitamin K1) 2. 5 mg PO.
C. protamine sulfate 20 mg PO.
D. protamine sulfate 20 mg slow IV push.
2. A patient who has chronic adrenal insufficiency is admitted to the hospital for an open
cholecystectomy. The nurse obtaining the admission history learns that the patient takes
hydrocortisone 25 mg PO daily in the morning. The patient's surgery is scheduled for the
next morning. The nurse will expect an order to:
A. administer the usual morning dose of hydrocortisone 25 mg PO.
B. administer hydrocortisone 75 mg PO in the morning.
C. administer hydrocortisone 75 mg IV before surgery.
D. withhold the morning dose of hydrocortisone and give it after surgery.
3. A patient who has been newly diagnosed with adrenal hormone deficiency will begin taking
hydrocortisone. The nurse provides teaching for this patient. Which statement by the patient
indicates understanding of the teaching?
A. "I may take all of my daily dose in the morning or divide it in half and take it twice
daily. "
, B. "I will need to take this medication until my symptoms completely clear, and then I
may stop. "
C. "Side effects are common with hydrocortisone, even with therapeutic doses. "
D. "When I am sick, I should take three times the normal dose for 3 days in a row.
"
4. The nurse is providing patient education about glucocorticoid therapy to a patient preparing
to be discharged home. Which statement made by the patient best demonstrates
understanding of glucocorticoid therapy?
A. "I will take the entire dose early with breakfast. "
B. "I may take two-thirds of the dose in the morning and one-third in the evening. "
C. "I will divide the dose in half and take half in the morning and half in the afternoon. "
D. "I will take a dose with each meal. "
5. A 50-year-old postmenopausal patient who has had a hysterectomy has moderate to severe
vasomotor symptoms and is discussing estrogen therapy (ET) with the nurse. The patient is
concerned about adverse effects of ET. The nurse will tell her that:
A. an estrogen-progesterone product will reduce side effects.
B. an intravaginal preparation may be best for her.
C. side effects of ET are uncommon among women her age.
D. transdermal preparations have fewer side effects.
6. A patient who is at risk for osteoporosis will begin taking the selective estrogen receptor
modulator raloxifene (Evista). Which statement will the nurse include when teaching this
patient about the medication?
, A. Raloxifene reduces the risk of thromboembolism.
B. The drug is associated with an increased risk of breast cancer.
C. Use of this drug increases the risk of endometrial carcinoma.
D. Vasomotor symptoms are a common side effect of this drug.
7. A nurse provides teaching to a patient who has had a hysterectomy and is about to begin
hormone therapy to manage menopausal symptoms. Which statement by the patient
indicates understanding of the teaching?
A. "Because I am not at risk for uterine cancer, I can take hormones indefinitely. "
B. "I can take estrogen to reduce my risk of cardiovascular disease. "
C. "I should take the lowest effective dose for the shortest time needed. "
D. "I will need a progestin/estrogen combination since I have had a hysterectomy. "
8. A nurse provides teaching to a group of nursing students about the risks and benefits of
hormone therapy (HT), including estrogen therapy (ET) and combination estrogen/progestin
therapy (EPT). Which statement by a student indicates understanding of the teaching?
A. "ET can provide protection against coronary heart disease and reverse osteoporosis. "
B. "EPT is generally safer than ET, especially in women who have undergone
hysterectomies. "
C. "In women with established coronary heart disease, EPT can protect against
myocardial infarction. "
D. "Principle benefits of ET are suppression of menopausal symptoms and
prevention of osteoporosis. "
9. A patient who will begin combination estrogen/progestin therapy (EPT) for menopause asks
the nurse why she can't take an estrogen-only preparation. The patient has not had a
, hysterectomy, has a slightly increased risk of cardiovascular disease, and has mild
osteopenia. The nurse will tell her that the progestin is necessary to:
A. decrease her risk of endometrial cancer.
B. increase bone resorption to prevent fractures.
C. lower her risk of myocardial infarction (MI).
D. prevent deep vein thrombosis (DVT).
10. The nurse is providing patient education for a postmenopausal patient who is considering
estrogen/progestin replacement therapy (EPT). Which risks associated with EPT should the
nurse discuss with the patient? (Select all that apply. )
A. Decreased colon cancer
B. Stroke
C. Deep vein thrombosis
D. Ovarian cancer
E. Decreased bone density
11. A nurse provides teaching for a female patient with anemia who has had cancer
chemotherapy and who will begin treatment with testosterone. Which statement by the
patient indicates understanding of the teaching?
A. "Facial hair may develop with this drug but will go away over time. "
B. "I may experience an increase in breast size while taking this drug. "
C. "Testosterone may increase my high-density lipoprotein (HDL) cholesterol and reduce
my low-density lipoprotein (LDL) cholesterol. "
D. "Testosterone treats anemia by stimulating the synthesis of a renal hormone. "
Nursing Final Exam Quiz Bank | Already Rated A| More
than 100 Questions and Answers| Rasmussen College
1. A patient who is taking warfarin (Coumadin) has just vomited blood. The nurse notifies the
provider, who orders lab work revealing a PT of 42 seconds and an INR of 3. 5. The nurse
will expect to administer:
A. phytonadione (vitamin K1) 1 mg IV over 1 hour.
B. phytonadione (vitamin K1) 2. 5 mg PO.
C. protamine sulfate 20 mg PO.
D. protamine sulfate 20 mg slow IV push.
2. A patient who has chronic adrenal insufficiency is admitted to the hospital for an open
cholecystectomy. The nurse obtaining the admission history learns that the patient takes
hydrocortisone 25 mg PO daily in the morning. The patient's surgery is scheduled for the
next morning. The nurse will expect an order to:
A. administer the usual morning dose of hydrocortisone 25 mg PO.
B. administer hydrocortisone 75 mg PO in the morning.
C. administer hydrocortisone 75 mg IV before surgery.
D. withhold the morning dose of hydrocortisone and give it after surgery.
3. A patient who has been newly diagnosed with adrenal hormone deficiency will begin taking
hydrocortisone. The nurse provides teaching for this patient. Which statement by the patient
indicates understanding of the teaching?
A. "I may take all of my daily dose in the morning or divide it in half and take it twice
daily. "
, B. "I will need to take this medication until my symptoms completely clear, and then I
may stop. "
C. "Side effects are common with hydrocortisone, even with therapeutic doses. "
D. "When I am sick, I should take three times the normal dose for 3 days in a row.
"
4. The nurse is providing patient education about glucocorticoid therapy to a patient preparing
to be discharged home. Which statement made by the patient best demonstrates
understanding of glucocorticoid therapy?
A. "I will take the entire dose early with breakfast. "
B. "I may take two-thirds of the dose in the morning and one-third in the evening. "
C. "I will divide the dose in half and take half in the morning and half in the afternoon. "
D. "I will take a dose with each meal. "
5. A 50-year-old postmenopausal patient who has had a hysterectomy has moderate to severe
vasomotor symptoms and is discussing estrogen therapy (ET) with the nurse. The patient is
concerned about adverse effects of ET. The nurse will tell her that:
A. an estrogen-progesterone product will reduce side effects.
B. an intravaginal preparation may be best for her.
C. side effects of ET are uncommon among women her age.
D. transdermal preparations have fewer side effects.
6. A patient who is at risk for osteoporosis will begin taking the selective estrogen receptor
modulator raloxifene (Evista). Which statement will the nurse include when teaching this
patient about the medication?
, A. Raloxifene reduces the risk of thromboembolism.
B. The drug is associated with an increased risk of breast cancer.
C. Use of this drug increases the risk of endometrial carcinoma.
D. Vasomotor symptoms are a common side effect of this drug.
7. A nurse provides teaching to a patient who has had a hysterectomy and is about to begin
hormone therapy to manage menopausal symptoms. Which statement by the patient
indicates understanding of the teaching?
A. "Because I am not at risk for uterine cancer, I can take hormones indefinitely. "
B. "I can take estrogen to reduce my risk of cardiovascular disease. "
C. "I should take the lowest effective dose for the shortest time needed. "
D. "I will need a progestin/estrogen combination since I have had a hysterectomy. "
8. A nurse provides teaching to a group of nursing students about the risks and benefits of
hormone therapy (HT), including estrogen therapy (ET) and combination estrogen/progestin
therapy (EPT). Which statement by a student indicates understanding of the teaching?
A. "ET can provide protection against coronary heart disease and reverse osteoporosis. "
B. "EPT is generally safer than ET, especially in women who have undergone
hysterectomies. "
C. "In women with established coronary heart disease, EPT can protect against
myocardial infarction. "
D. "Principle benefits of ET are suppression of menopausal symptoms and
prevention of osteoporosis. "
9. A patient who will begin combination estrogen/progestin therapy (EPT) for menopause asks
the nurse why she can't take an estrogen-only preparation. The patient has not had a
, hysterectomy, has a slightly increased risk of cardiovascular disease, and has mild
osteopenia. The nurse will tell her that the progestin is necessary to:
A. decrease her risk of endometrial cancer.
B. increase bone resorption to prevent fractures.
C. lower her risk of myocardial infarction (MI).
D. prevent deep vein thrombosis (DVT).
10. The nurse is providing patient education for a postmenopausal patient who is considering
estrogen/progestin replacement therapy (EPT). Which risks associated with EPT should the
nurse discuss with the patient? (Select all that apply. )
A. Decreased colon cancer
B. Stroke
C. Deep vein thrombosis
D. Ovarian cancer
E. Decreased bone density
11. A nurse provides teaching for a female patient with anemia who has had cancer
chemotherapy and who will begin treatment with testosterone. Which statement by the
patient indicates understanding of the teaching?
A. "Facial hair may develop with this drug but will go away over time. "
B. "I may experience an increase in breast size while taking this drug. "
C. "Testosterone may increase my high-density lipoprotein (HDL) cholesterol and reduce
my low-density lipoprotein (LDL) cholesterol. "
D. "Testosterone treats anemia by stimulating the synthesis of a renal hormone. "
